Field Trip Health Ltd. - News

2022 2021 2020 2019

05/12/2022

Field Trip and Nue Life Are Collaborating To Bring Psychedelic Therapy Into the Home

04/29/2022

Field Trip Health Ltd. to Participate in Upcoming Investor Conferences in May 2022

04/28/2022

Field Trip Health Ltd. Announces Intention to Separate the Field Trip Discovery and Field Trip Health Divisions Into Two Independent Public Companies

04/18/2022

Field Trip Health Ltd. to Participate in Upcoming Investor Conferences

04/05/2022

Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule FT-104

03/23/2022

Field Trip Health Ltd. to Participate in Maxim Group 2nd Annual Virtual Growth Conference

03/09/2022

Field Trip Health Ltd. to Participate in 34th Annual Roth Conference in March 2022

03/03/2022

Field Trip Health and Cerebral Partner to Provide End-to-End Mental Health Care

02/15/2022

Field Trip Health Ltd. Reports Third Fiscal Quarter 2022 Financial Results and Provides Business Update

02/01/2022

Field Trip Health Ltd. Schedules Third Fiscal Quarter 2022 Financial Results Conference Call for February 16, 2022 at 8:30 AM ET

01/18/2022

Field Trip Health Ltd. to Participate in Citi’s Psychedelic Drug Video Call Series

01/11/2022

Field Trip Receives Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate), its Novel Psychedelic Molecule in Development

01/06/2022

Field Trip Announces Intention to Make Applications on Behalf of Patients to Health Canada’s Special Access Program (SAP) for Access to Psilocybin and MDMA-Assisted Therapies

01/05/2022

Field Trip Health Ltd. to Participate in H.C. Wainwright Bioconnect Virtual Conference in January 2022